Wick W - Search Results

1

Gliomatosis cerebri: molecular pathology and clinical course.

Herrlinger U, Felsberg J, Küker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M. Herrlinger U, et al. Among authors: wick w. Ann Neurol. 2002 Oct;52(4):390-9. doi: 10.1002/ana.10297. Ann Neurol. 2002. PMID: 12325066

2

Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase.

Wick W, Wick A, Schulz JB, Dichgans J, Rodemann HP, Weller M. Wick W, et al. Among authors: wick a. Cancer Res. 2002 Mar 15;62(6):1915-9. Cancer Res. 2002. PMID: 11912174

3

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

Fulda S, Wick W, Weller M, Debatin KM. Fulda S, et al. Among authors: wick w. Nat Med. 2002 Aug;8(8):808-15. doi: 10.1038/nm735. Epub 2002 Jul 15. Nat Med. 2002. PMID: 12118245

4

Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt.

Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB. Wick A, et al. Among authors: wick w. J Neurosci. 2002 Aug 1;22(15):6401-7. doi: 10.1523/JNEUROSCI.22-15-06401.2002. J Neurosci. 2002. PMID: 12151519 Free PMC article.

5

Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study.

Wick W, Hermisson M, Kortmann RD, Küker WM, Duffner F, Dichgans J, Bamberg M, Weller M. Wick W, et al. J Neurooncol. 2002 Sep;59(2):151-5. doi: 10.1023/a:1019641314661. J Neurooncol. 2002. PMID: 12241108 Clinical Trial.

6

Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins.

Rieger J, Wick W, Weller M. Rieger J, et al. Among authors: wick w. Glia. 2003 Jun;42(4):379-89. doi: 10.1002/glia.10210. Glia. 2003. PMID: 12730958

7

Adenoviral natural born killer gene therapy for malignant glioma.

Naumann U, Schmidt F, Wick W, Frank B, Weit S, Gillissen B, Daniel P, Weller M. Naumann U, et al. Among authors: wick w. Hum Gene Ther. 2003 Sep 1;14(13):1235-46. doi: 10.1089/104303403767740777. Hum Gene Ther. 2003. PMID: 12952595

8

P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells.

Bähr O, Rieger J, Duffner F, Meyermann R, Weller M, Wick W. Bähr O, et al. Among authors: wick w. Brain Pathol. 2003 Oct;13(4):482-94. doi: 10.1111/j.1750-3639.2003.tb00479.x. Brain Pathol. 2003. PMID: 14655754 Free PMC article.

9

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

Friese MA, Wischhusen J, Wick W, Weiler M, Eisele G, Steinle A, Weller M. Friese MA, et al. Among authors: wick w. Cancer Res. 2004 Oct 15;64(20):7596-603. doi: 10.1158/0008-5472.CAN-04-1627. Cancer Res. 2004. PMID: 15492287

10

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.

Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M. Uhl M, et al. Among authors: wick w. Cancer Res. 2004 Nov 1;64(21):7954-61. doi: 10.1158/0008-5472.CAN-04-1013. Cancer Res. 2004. PMID: 15520202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

713 results

Search Page

Filters